As Cilta-Cel’s Big Day Approaches, Legend Looks Beyond Myeloma

Company To Go Solo With T-Cell Lymphoma Program

 
• By Alaric DeArment

CEO Ying Huang talked about the biotech’s plans for CAR-T therapies after its J&J-partnered program.  

Open Book Of prostate multiple myeloma, Conceptual Image - Image
• Source: Shutterstock

More from Clinical Trials

More from R&D